Omeprazolo Ranbaxy Italia (Omeprazole)

Omeprazole, the active ingredient in Omeprazolo Ranbaxy Italia, is a Proton Pump Inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders in adults and children. GNH USA supplies Omeprazolo Ranbaxy Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazolo Ranbaxy Italia is a proton‑pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑oesophageal reflux disease (GERD): alleviates symptoms and promotes healing of the oesophageal lining. - Peptic ulcer disease (PUD): supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - Erosive oesophagitis: heals erosive damage to the oesophagus. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: renal inflammation. - Hypomagnesemia: low serum magnesium levels. - Stevens‑Johnson syndrome: severe skin reaction. - Liver enzyme elevation: potential hepatic impact. - Fracture risk: possible decreased bone density with long‑term use.

When prescribing Omeprazolo Ranbaxy Italia, clinicians should consider several safety aspects: - Assess renal function: adjust use in severe impairment. - Evaluate hepatic function: use with caution in liver disease. - Review long‑term therapy: monitor for bone density loss. - Consider infection risk: be alert for Clostridioides difficile symptoms. - Pregnancy and lactation: weigh benefits against potential risks. - Store at below 25°C: keep in the original packaging, protect from moisture and light.

Omeprazole may interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased antiviral absorption. - Methotrexate: increased serum concentration.

Moderate Interactions (Monitor Closely): - Warfarin: potential INR elevation. - Phenytoin: altered plasma levels. - Digoxin: possible increase in serum concentration.